{"id":237394,"date":"2026-09-09T12:26:11","date_gmt":"2026-09-09T06:56:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=237394"},"modified":"2026-09-09T12:26:11","modified_gmt":"2026-09-09T06:56:11","slug":"artemis-medicare-services-q2-results-fy27-preview-date-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/","title":{"rendered":"Artemis Medicare Services Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Artemis Medicare Services share price Rs 346.15 on 9 September 2026, up 1.20%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 31.00 crore. Q2 FY26 base a profit of Rs 30.00 crore.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Artemis Medicare Services Q2 results date for FY27 is not confirmed, and Artemis Medicare Services Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 275.00 crore in revenue and a profit of Rs 30.00 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.<\/p>\n<\/p><\/div>\n<p>The Artemis Medicare Services Q2 results FY27 announcement is the next scheduled earnings event for <a href=\"https:\/\/univest.in\/stocks\/artemismed\/artemis-medicare-services-ltd-share-price-today\">Artemis Medicare Services Ltd.<\/a>, the operator of the Artemis multi-specialty tertiary care hospitals in Gurugram, covering cardiology, oncology, neurosciences, orthopaedics and critical care. The stock traded at Rs 346.15 on the NSE on 9 September 2026, up 1.20% from the previous close of Rs 342.05, about 1.1% below its 52-week high of Rs 350.00 and 70.2% above its 52-week low of Rs 203.35.<\/p>\n<p>What makes the Artemis Medicare Services Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 275.00 crore of revenue and a profit of Rs 30.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 287.00 crore and a profit of Rs 31.00 crore. Everything below is built from those reported figures rather than from any forecast.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=artemismed_q2_fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#When_Is_the_Artemis_Medicare_Services_Q2_Results_FY27_Date\" title=\"When Is the Artemis Medicare Services Q2 Results FY27 Date?\">When Is the Artemis Medicare Services Q2 Results FY27 Date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Artemis_Medicare_Services_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\" title=\"Artemis Medicare Services Q2 Results Expectations: What the Market Is Actually Tracking\">Artemis Medicare Services Q2 Results Expectations: What the Market Is Actually Tracking<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Artemis_Medicare_Services_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\" title=\"Artemis Medicare Services Q2 Results Preview: The Q1 FY27 Actuals It Builds On\">Artemis Medicare Services Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Q2_FY26_Base_The_Comparison_Artemis_Medicare_Services_Q2_Results_FY27_Must_Beat\" title=\"Q2 FY26 Base: The Comparison Artemis Medicare Services Q2 Results FY27 Must Beat\">Q2 FY26 Base: The Comparison Artemis Medicare Services Q2 Results FY27 Must Beat<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Artemis_Medicare_Services_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\" title=\"Artemis Medicare Services Quarterly Results Trend Over the Last Four Quarters\">Artemis Medicare Services Quarterly Results Trend Over the Last Four Quarters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Key_Factors_That_Could_Shape_Artemis_Medicare_Services_Q2_Results_FY27\" title=\"Key Factors That Could Shape Artemis Medicare Services Q2 Results FY27\">Key Factors That Could Shape Artemis Medicare Services Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Occupancy_and_Case_Mix\" title=\"Occupancy and Case Mix\">Occupancy and Case Mix<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Payer_Mix_Between_Cash_and_Insurance\" title=\"Payer Mix Between Cash and Insurance\">Payer Mix Between Cash and Insurance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#High_Multiple_Near_a_52-Week_High\" title=\"High Multiple Near a 52-Week High\">High Multiple Near a 52-Week High<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Artemis_Medicare_Services_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\" title=\"Artemis Medicare Services Q2 Results FY27: Share Price and Valuation Going Into the Print\">Artemis Medicare Services Q2 Results FY27: Share Price and Valuation Going Into the Print<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#What_Investors_Should_Watch_When_Artemis_Medicare_Services_Q2_Results_Are_Announced\" title=\"What Investors Should Watch When Artemis Medicare Services Q2 Results Are Announced\">What Investors Should Watch When Artemis Medicare Services Q2 Results Are Announced<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Conclusion_on_Artemis_Medicare_Services_Q2_Results_FY27\" title=\"Conclusion on Artemis Medicare Services Q2 Results FY27\">Conclusion on Artemis Medicare Services Q2 Results FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#FAQs_on_Artemis_Medicare_Services_Q2_Results_FY27\" title=\"FAQs on Artemis Medicare Services Q2 Results FY27\">FAQs on Artemis Medicare Services Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#What_is_the_Artemis_Medicare_Services_Q2_results_date_for_FY27\" title=\"What is the Artemis Medicare Services Q2 results date for FY27?\">What is the Artemis Medicare Services Q2 results date for FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#What_quarter_do_the_Artemis_Medicare_Services_Q2_results_2026_cover\" title=\"What quarter do the Artemis Medicare Services Q2 results 2026 cover?\">What quarter do the Artemis Medicare Services Q2 results 2026 cover?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#What_were_the_Artemis_Medicare_Services_Q1_FY27_results\" title=\"What were the Artemis Medicare Services Q1 FY27 results?\">What were the Artemis Medicare Services Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#What_were_Artemis_Medicare_Services_Q2_FY26_results_in_the_September_2025_quarter\" title=\"What were Artemis Medicare Services Q2 FY26 results in the September 2025 quarter?\">What were Artemis Medicare Services Q2 FY26 results in the September 2025 quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#What_are_the_main_Artemis_Medicare_Services_Q2_results_expectations_this_quarter\" title=\"What are the main Artemis Medicare Services Q2 results expectations this quarter?\">What are the main Artemis Medicare Services Q2 results expectations this quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#What_is_Artemis_Medicare_Services_share_price_today_ahead_of_the_Q2_earnings\" title=\"What is Artemis Medicare Services share price today ahead of the Q2 earnings?\">What is Artemis Medicare Services share price today ahead of the Q2 earnings?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/artemis-medicare-services-q2-results-fy27-preview-date-expectations\/#Is_Artemis_Medicare_Services_a_good_stock_to_buy_before_the_Q2_results\" title=\"Is Artemis Medicare Services a good stock to buy before the Q2 results?\">Is Artemis Medicare Services a good stock to buy before the Q2 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"When_Is_the_Artemis_Medicare_Services_Q2_Results_FY27_Date\"><\/span><strong>When Is the Artemis Medicare Services Q2 Results FY27 Date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Artemis Medicare Services Q2 results date for FY27 is not confirmed. As of 9 September 2026, Artemis Medicare Services Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.<\/p>\n<p>What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Artemis Medicare Services Q2 results date becomes public through that filing rather than through any advance announcement.<\/p>\n<p>The Artemis Medicare Services Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Artemis Medicare Services.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Artemis_Medicare_Services_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\"><\/span><strong>Artemis Medicare Services Q2 Results Expectations: What the Market Is Actually Tracking<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No verified analyst estimate for the Artemis Medicare Services Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Artemis Medicare Services. The Artemis Medicare Services Q2 results watchlist below is built from what the company has actually reported and disclosed.<\/p>\n<p>The first is the margin, which has improved steadily. Operating margin moved from 16% in June 2025 to 20% in Q1 FY27, and the September 2025 base of 18% sits below the current level even though revenue has grown only modestly.<\/p>\n<p>The second is that revenue has been remarkably steady, running between Rs 255 crore and Rs 287 crore across all five quarters. For a single-campus hospital that reflects a bed base near capacity rather than an expanding footprint.<\/p>\n<p>The third is the September 2025 base of Rs 275 crore in revenue and Rs 30 crore of profit, the joint best profit quarter of the five at that time. The year-on-year comparison therefore starts from a solid rather than a soft number.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Artemis Medicare Services Ltd. Live Fundamentals on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Artemis_Medicare_Services_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\"><\/span><strong>Artemis Medicare Services Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Artemis Medicare Services Ltd. reported revenue of Rs 287.00 crore in Q1 FY27, up 12.55% from Rs 255.00 crore in Q1 FY26, and a profit of Rs 31.00 crore at the net level, up 47.62% from Rs 21.00 crore in Q1 FY26. These are reported actuals, not estimates.<\/p>\n<p>Sequentially, revenue was up 2.87% over the March 2026 quarter figure of Rs 279.00 crore, and net profit was up 3.33% from Rs 30.00 crore in Q4 FY26. Operating margin stood at 20% in Q1 FY27 against 18% in the September 2025 quarter, which is the comparison the Artemis Medicare Services Q2 results print will be read against.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_FY26_Base_The_Comparison_Artemis_Medicare_Services_Q2_Results_FY27_Must_Beat\"><\/span><strong>Q2 FY26 Base: The Comparison Artemis Medicare Services Q2 Results FY27 Must Beat<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Artemis Medicare Services Ltd. reported revenue of Rs 275.00 crore and a profit of Rs 30.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Artemis Medicare Services Q2 results preview.<\/p>\n<p>Net profit in that base quarter was below the Rs 31.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 275.00 crore sits below the Rs 287.00 crore of the June 2026 quarter, which frames how much sequential movement the Artemis Medicare Services Q2 results print needs to show growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Artemis_Medicare_Services_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\"><\/span><strong>Artemis Medicare Services Quarterly Results Trend Over the Last Four Quarters<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Revenue (Rs Cr)<\/th>\n<th>Net Profit (Rs Cr)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Q2 FY26 (Sep 2025)<\/td>\n<td>275.00<\/td>\n<td>30.00<\/td>\n<\/tr>\n<tr>\n<td>Q3 FY26 (Dec 2025)<\/td>\n<td>272.00<\/td>\n<td>22.00<\/td>\n<\/tr>\n<tr>\n<td>Q4 FY26 (Mar 2026)<\/td>\n<td>279.00<\/td>\n<td>30.00<\/td>\n<\/tr>\n<tr>\n<td>Q1 FY27 (Jun 2026)<\/td>\n<td>287.00<\/td>\n<td>31.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company&#8217;s exchange filings, and they are the only basis this Artemis Medicare Services Q2 results preview uses.<\/p>\n<p>Revenue across those four quarters ranged from Rs 272.00 crore to Rs 287.00 crore, and net profit from Rs 22.00 crore to Rs 31.00 crore. That spread is the honest context for the Artemis Medicare Services Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_That_Could_Shape_Artemis_Medicare_Services_Q2_Results_FY27\"><\/span><strong>Key Factors That Could Shape Artemis Medicare Services Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Artemis Medicare Services Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Artemis Medicare Services has already reported.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Occupancy_and_Case_Mix\"><\/span><strong>Occupancy and Case Mix<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>With a largely fixed bed count, profitability depends on how full those beds are and what each case earns. A shift toward higher-value specialties raises revenue per occupied bed without needing more capacity.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Payer_Mix_Between_Cash_and_Insurance\"><\/span><strong>Payer Mix Between Cash and Insurance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The balance between self-paying patients, insurance and corporate contracts sets realisation per case. That mix moves margin more than headline patient volumes do, and it is what the results commentary should address.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"High_Multiple_Near_a_52-Week_High\"><\/span><strong>High Multiple Near a 52-Week High<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades at a price-to-earnings ratio of 47.27 and 5.87 times a book value of Rs 59.00, on a return on equity of 12.00%. It sits at Rs 346.15 against a 52-week high of Rs 350.00.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Artemis_Medicare_Services_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\"><\/span><strong>Artemis Medicare Services Q2 Results FY27: Share Price and Valuation Going Into the Print<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Artemis Medicare Services share price today is Rs 346.15 on the NSE, up Rs 4.10 or 1.20% from the previous close of Rs 342.05 on 9 September 2026, ahead of the Artemis Medicare Services Q2 results announcement.<\/p>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Value (9 September 2026)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>ARTEMISMED<\/td>\n<\/tr>\n<tr>\n<td>Current Market Price<\/td>\n<td>Rs 346.15<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 350.00<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 203.35<\/td>\n<\/tr>\n<tr>\n<td>Market Capitalisation<\/td>\n<td>Rs 5,481 crore<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio<\/td>\n<td>47.27<\/td>\n<\/tr>\n<tr>\n<td>PB Ratio<\/td>\n<td>5.87<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM)<\/td>\n<td>Rs 7.32<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share<\/td>\n<td>Rs 59.00<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.28<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity<\/td>\n<td>12.00%<\/td>\n<\/tr>\n<tr>\n<td>50-Day Moving Average<\/td>\n<td>Rs 301.06<\/td>\n<\/tr>\n<tr>\n<td>200-Day Moving Average<\/td>\n<td>Rs 264.75<\/td>\n<\/tr>\n<tr>\n<td>RSI (14)<\/td>\n<td>67.34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock trades above both its 50-day average of Rs 301.06 and its 200-day average of Rs 264.75, with a 14-day RSI of 67.34. None of this is a view on where the shares go once the Artemis Medicare Services Q2 results are announced, and no price target is offered here.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Artemis Medicare Services Ltd. live price and quarterly earnings updates.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Investors_Should_Watch_When_Artemis_Medicare_Services_Q2_Results_Are_Announced\"><\/span><strong>What Investors Should Watch When Artemis Medicare Services Q2 Results Are Announced<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four lines carry most of the information in a company of this size, and reading them in order keeps the Artemis Medicare Services Q2 results print in proportion.<\/p>\n<ol>\n<li>Revenue against the Rs 275.00 crore reported in the September 2025 base quarter<\/li>\n<li>Net profit against a profit of Rs 30.00 crore in that same quarter<\/li>\n<li>Operating margin against 20% in Q1 FY27<\/li>\n<li>Any exceptional item, provision or one-off gain disclosed alongside the numbers<\/li>\n<\/ol>\n<p>A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Artemis Medicare Services Q2 results announcement should be read together with the notes to the results rather than the headline alone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_on_Artemis_Medicare_Services_Q2_Results_FY27\"><\/span><strong>Conclusion on Artemis Medicare Services Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Artemis Medicare Services Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Artemis Medicare Services Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.<\/p>\n<p>On that basis the Artemis Medicare Services Q2 results FY27 print faces a base of Rs 275.00 crore in revenue and a profit of Rs 30.00 crore, with the most recent quarter having delivered Rs 287.00 crore and a profit of Rs 31.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Artemis Medicare Services, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Artemis_Medicare_Services_Q2_Results_FY27\"><\/span><strong>FAQs on Artemis Medicare Services Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Artemis_Medicare_Services_Q2_results_date_for_FY27\"><\/span><strong>What is the Artemis Medicare Services Q2 results date for FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Artemis Medicare Services Q2 results date for FY27 is not confirmed. Artemis Medicare Services Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_quarter_do_the_Artemis_Medicare_Services_Q2_results_2026_cover\"><\/span><strong>What quarter do the Artemis Medicare Services Q2 results 2026 cover?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Artemis Medicare Services Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Artemis Medicare Services Ltd. reports revenue, operating profit and net profit for that period, and the Artemis Medicare Services Q2 results filing also carries the notes to the accounts.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_Artemis_Medicare_Services_Q1_FY27_results\"><\/span><strong>What were the Artemis Medicare Services Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Artemis Medicare Services Ltd. reported revenue of Rs 287.00 crore in Q1 FY27 and a profit of Rs 31.00 crore at the net level. Revenue was up 12.55% versus Q1 FY26 and net profit was up 47.62% from Rs 21.00 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Artemis_Medicare_Services_Q2_FY26_results_in_the_September_2025_quarter\"><\/span><strong>What were Artemis Medicare Services Q2 FY26 results in the September 2025 quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Artemis Medicare Services Ltd. reported revenue of Rs 275.00 crore and a profit of Rs 30.00 crore in Q2 FY26. Operating margin was 18%. Those figures form the base for the Artemis Medicare Services Q2 results FY27 comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_Artemis_Medicare_Services_Q2_results_expectations_this_quarter\"><\/span><strong>What are the main Artemis Medicare Services Q2 results expectations this quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No verified analyst estimate is publicly available. The Artemis Medicare Services Q2 results expectations centre on revenue against the Rs 275.00 crore base, net profit against a profit of Rs 30.00 crore, operating margin against 20% in Q1 FY27, and any exceptional item disclosed with the numbers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Artemis_Medicare_Services_share_price_today_ahead_of_the_Q2_earnings\"><\/span><strong>What is Artemis Medicare Services share price today ahead of the Q2 earnings?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Artemis Medicare Services share price is Rs 346.15 on the NSE as of 9 September 2026, up 1.20% from Rs 342.05. The stock is about 1.1% below its 52-week high of Rs 350.00 and 70.2% above its 52-week low of Rs 203.35, at a market capitalisation of Rs 5,481 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Artemis_Medicare_Services_a_good_stock_to_buy_before_the_Q2_results\"><\/span><strong>Is Artemis Medicare Services a good stock to buy before the Q2 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article does not offer a buy, sell or hold recommendation on Artemis Medicare Services Ltd.. The stock trades at a price-to-book ratio of 5.87 with a return on equity of 12.00%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Artemis Medicare Services Q2 results date for FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Artemis Medicare Services Q2 results date for FY27 is not confirmed. Artemis Medicare Services Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.\"}},{\"@type\":\"Question\",\"name\":\"What quarter do the Artemis Medicare Services Q2 results 2026 cover?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Artemis Medicare Services Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Artemis Medicare Services Ltd. reports revenue, operating profit and net profit for that period, and the Artemis Medicare Services Q2 results filing also carries the notes to the accounts.\"}},{\"@type\":\"Question\",\"name\":\"What were the Artemis Medicare Services Q1 FY27 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Artemis Medicare Services Ltd. reported revenue of Rs 287.00 crore in Q1 FY27 and a profit of Rs 31.00 crore at the net level. Revenue was up 12.55% versus Q1 FY26 and net profit was up 47.62% from Rs 21.00 crore in Q1 FY26.\"}},{\"@type\":\"Question\",\"name\":\"What were Artemis Medicare Services Q2 FY26 results in the September 2025 quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Artemis Medicare Services Ltd. reported revenue of Rs 275.00 crore and a profit of Rs 30.00 crore in Q2 FY26. Operating margin was 18%. Those figures form the base for the Artemis Medicare Services Q2 results FY27 comparison.\"}},{\"@type\":\"Question\",\"name\":\"What are the main Artemis Medicare Services Q2 results expectations this quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No verified analyst estimate is publicly available. The Artemis Medicare Services Q2 results expectations centre on revenue against the Rs 275.00 crore base, net profit against a profit of Rs 30.00 crore, operating margin against 20% in Q1 FY27, and any exceptional item disclosed with the numbers.\"}},{\"@type\":\"Question\",\"name\":\"What is Artemis Medicare Services share price today ahead of the Q2 earnings?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Artemis Medicare Services share price is Rs 346.15 on the NSE as of 9 September 2026, up 1.20% from Rs 342.05. The stock is about 1.1% below its 52-week high of Rs 350.00 and 70.2% above its 52-week low of Rs 203.35, at a market capitalisation of Rs 5,481 crore.\"}},{\"@type\":\"Question\",\"name\":\"Is Artemis Medicare Services a good stock to buy before the Q2 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This article does not offer a buy, sell or hold recommendation on Artemis Medicare Services Ltd.. The stock trades at a price-to-book ratio of 5.87 with a return on equity of 12.00%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Artemis Medicare Services Q2 results FY27 date is not yet confirmed by the exchanges. Here is the September 2026 quarter watchlist for Artemis Medicare Services Ltd., built on actual Q1 FY27 and Q2 FY26 numbers with no invented estimates.<\/p>\n","protected":false},"author":29,"featured_media":237393,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-237394","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["237393"],"rank_math_title":["Artemis Medicare Q2 Results FY27: Date and Outlook"],"rank_math_description":["Artemis Medicare Services Q2 results FY27 preview: results date status, key expectations, Q1 FY27 and Q2 FY26 actuals plus valuation before the September 2026 print."],"rank_math_focus_keyword":["Artemis Medicare Services Q2 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/artemis-medicare-services-q2-results-fy27-preview-date-expectations.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/237394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=237394"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/237394\/revisions"}],"predecessor-version":[{"id":237395,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/237394\/revisions\/237395"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/237393"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=237394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=237394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=237394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}